A case report of moderate COVID-19 with an extremely long-term viral shedding period
International Journal of Clinical and Experimental Medicine
; 15(7):231-235, 2022.
Article
in English
| EMBASE | ID: covidwho-1976313
ABSTRACT
Background:
COVID-19 is caused by infection with a new form of coronavirus (SARS-CoV-2). The WHO raised the COVID-19 alert to the highest level. The virus is a highly contagious via human-to-human transmission. The median duration of viral shedding is 20.0 days. We report a long duration of viral shedding that was 32.0 days from illness onset in a patient with moderate COVID-19 admitted to Qianjiang Central Hospital. Case report A 37-year-old patient sought medical advice while suffering from fever, dry cough, fatigue, dizziness, runny nose and diarrhoea. Five days before the visit, he had a history of travel from affected geographic areas. The patient had a positive RT-PCR test, and chest CT images showed multiple nodules and mixed ground-glass opacification with consolidation in bilaterally in the lungs. Laboratory findings showed that the lymphocyte and CD4+ counts were below the normal range. The patient was given antiviral treatment, including arbidol, lopinavir, IFN-α, and traditional Chinese medicine, and other necessary supportive care. All clinical symptoms and CT imaging manifestation ab-normalities resolved during the course of therapy.Conclusion:
Although the positive RT-PCR tests were verified in consecutive upper respiratory specimens, the patient’s clinical symptoms, CT imaging findings, CD4+ lymphocyte counts, and IgG antibody levels had obviously improved. Positive tests may be detecting pieces of inactive viruses, which would not be transmissible in individual cases.
adult; antiviral therapy; article; case report; CD4+ T lymphocyte; Chinese medicine; clinical article; coronavirus disease 2019; diarrhea; dizziness; drug therapy; dry cough; fatigue; fever; ground glass opacity; human; human cell; lymphocyte; lymphocyte count; male; rhinorrhea; thorax; travel; virus shedding; alpha interferon; CD4 antigen; endogenous compound; immunoglobulin G antibody; lopinavir; umifenovir
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Topics:
Long Covid
Language:
English
Journal:
International Journal of Clinical and Experimental Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS